New Fund To Buy Expensive Cancer Drugs

Heather, a cancer patient, faces challenges as her cancer spreads despite surgery and chemotherapy. A new drug, Avastin, could extend her life, but it's deemed too costly by the NHS. Heather hopes to access it through the new Cancer Drugs Fund, which has £50 million for unapproved drugs. The fund is welcomed by charities for offering more treatment options, but some economists argue the money could be better spent. The fund aims to help patients in England access drugs available in other countries.

What impact does Heather hope to have on her grandchildren's lives?

What concerns do health economists have regarding the Cancer Drugs Fund?